A critical sample obtained during hypoglycemia indicated suppressed insulin (<0.20 μIU/mL) and C-peptide (0.12 ng/mL) levels, thereby effectively excluding insulinoma and factitious hypoglycemia. The gene discussed is INS; the disease is pancreatic insulinoma.